Neuropeptide conversion to bioactive fragments--an important pathway in neuromodulation.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Current protein and peptide science

• Publication date

  2003-01-31

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/1389203033380313PMID 12570783
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reinforcing effects of peripherally administered substance P and its C-terminal sequence pGlu6-SP6-11 in the rat

  2005cited by this paper
• Biological properties of the angiotensin peptides other than angiotensin II: implications for hypertension and cardiovascular diseases

  2002cited by this paper
• Upregulation of neurokinin‐1 receptor expression in rat spinal cord by an N‐terminal metabolite of substance P

  2002cited by this paper
• The NK1 receptor mediates both the hyperalgesia and the resistance to morphine in mice lacking noradrenaline

  2002cited by this paper
• Effects of nociceptin (13-17) in pain modulation at supraspinal level in mice.

  2002cited by this paper
• Anxiolytic-like effects of substance P fragment (SP(1-7)) in non-human primates (Callithrix penicillata).

  2002cited by this paper
• Degradation of nociceptin (orphanin FQ) by mouse spinal cord synaptic membranes is triggered by endopeptidase-24.11: an in vitro and in vivo study.

  2002cited by this paper
• The orphanin FQ/nociceptin knockout mouse: a behavioral model for stress responses.

  2002cited by this paper
• The Tachykinin Peptide Family

  2002cited by this paper
• Elevated plasma nociceptin level in patients with Wilson disease.

  2002cited by this paper
• Injection of substance P (SP) N-terminal fragment SP(1-7) into the ventral tegmental area modulates the levels of nucleus accumbens dopamine and dihydroxyphenylacetic acid in male rats during morphine withdrawal.

  2002cited by this paper
• Pronociceptive effects of nociceptin/orphanin FQ (13-17) at peripheral and spinal level in mice.

  2001cited by this paper
• Evidence That the Angiotensin IV (AT4) Receptor Is the Enzyme Insulin-regulated Aminopeptidase*

  2001cited by this paper
• Characterization of CGRP(1) receptors in the guinea pig basilar artery.

  2001cited by this paper
• Investigation of the metabolism of substance P at the blood‐brain barrier using capillary electrophoresis with laser‐induced fluorescence detection

  2001cited by this paper
• Opposite effects of substance P fragments C (anxiogenic) and N (anxiolytic) injected into dorsal periaqueductal gray.

  2001cited by this paper
• Molecular Cloning and Pharmacological Characterization of the Canine B1 and B2 Bradykinin Receptors

  2001cited by this paper
• Angiotensin II type 2 receptor-mediated duodenal mucosal alkaline secretion in the rat.

  2001cited by this paper
• Substance P Abolishes the Facilitatory Effect of ATP on Spontaneous Glycine Release in Neurons of the Trigeminal Nucleus Pars Caudalis

  2001cited by this paper
• Kinin receptors in pain and inflammation.

  2001cited by this paper
• The differential effect of angiotensin II and angiotensin 1-7 on norepinephrine, epinephrine, and dopamine concentrations in rat hypothalamus: the involvement of angiotensin receptors.

  2001cited by this paper
• Orphanin FQ produces gender-specific modulation of trigeminal nociception: behavioral and electrophysiological observations.

  2001cited by this paper
• Role of Neurotransmitters in Sensitization of Pain Responses

  2001cited by this paper
• Calcitonin gene-related peptide released within the amygdala is involved in Pavlovian auditory fear conditioning.

  2001cited by this paper
• Substance p.

  2001cited by this paper
• The effects of angiotensin IV analogs on long-term potentiation within the CA1 region of the hippocampus in vitro.

  2001cited by this paper
• A role for the angiotensin AT4 receptor subtype in overcoming scopolamine-induced spatial memory deficits.

  2001cited by this paper
• Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function.

  2001cited by this paper
• Opioids and cardioprotection.

  2001cited by this paper
• Potentiation of cholinergic transmission in the rat hippocampus by angiotensin IV and LVV-hemorphin-7.

  2001cited by this paper
• Possible contribution of brain angiotensin III to ingestive behaviors in baboons.

  2001cited by this paper
• Vasoactive Potential of the B1 Bradykinin Receptor in Normotension and Hypertension

  2001cited by this paper
• Substance P endopeptidase-like activity is altered in various regions of the rat central nervous system during morphine tolerance and withdrawal.

  2001cited by this paper
• Investigation of the metabolism of substance P in rat striatum by microdialysis sampling and capillary electrophoresis with laser-induced fluorescence detection.

  2001cited by this paper
• An alternatively spliced transcript of the rat nociceptin receptor ORL1 gene encodes a truncated receptor.

  2000cited by this paper
• Distribution of angiotensin IV binding sites (AT4 receptor) in the human forebrain, midbrain and pons as visualised by in vitro receptor autoradiography.

  2000cited by this paper
• Rewarding effects of opiates are absent in mice lacking the receptor for substance P

  2000cited by this paper
• Endogenous opioids and reward.

  2000cited by this paper
• Angiotensin peptides and baroreflex control of sympathetic outflow: pathways and mechanisms of the medulla oblongata.

  2000cited by this paper
• Anabolic-androgenic steroids affect the content of substance P and substance P(1-7) in the rat brain.

  2000cited by this paper
• Anxiolytic-like effects in rats produced by ventral pallidal injection of both N- and C-terminal fragments of substance P.

  2000cited by this paper
• Differential effects of angiotensin II and angiotensin-(1-7) at the nucleus tractus solitarii of transgenic rats with low brain angiotensinogen

  2000cited by this paper
• International union of pharmacology. XXIII. The angiotensin II receptors.

  2000cited by this paper
• Intracerebroventricular injection of the N-terminal substance P fragment SP(1-7) regulates the expression of the N-methyl-D-aspartate receptor NR1, NR2A and NR2B subunit mRNAs in the rat brain.

  2000cited by this paper
• Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors.

  2000cited by this paper
• Substance P antagonists: novel agents in the treatment of depression

  2000cited by this paper
• Evidence that N-terminal fragments of nociceptin modulate nociceptin-induced scratching, biting and licking in mice.

  2000cited by this paper
• Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.

  1999cited by this paper
• Angiotensin II is a growth factor in the peri‐implantation rat embryo

  1999cited by this paper
• Identification of a high‐affinity orphanin FQ/nociceptin(1–11) binding site in mouse brain

  1999cited by this paper
• Orphanin FQ, a novel neuropeptide with anti-stress-like activity.

  1999cited by this paper
• Calcitonin gene-related peptide gene expression in collagen-induced arthritis is differentially regulated in primary afferents and motoneurons: influence of glucocorticoids.

  1999cited by this paper
• Specific calcitonin gene-related peptide binding sites present throughout rat intestine.

  1999cited by this paper
• Nociceptin‐induced scratching, biting and licking in mice: involvement of spinal NK1 receptors

  1999cited by this paper
• Genetic enhancement of learning and memory in mice

  1999cited by this paper
• Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat

  1999cited by this paper
• Peptide hormone precursor processing: getting sorted?

  1999cited by this paper
• Kallidin- and bradykinin-degrading pathways in human heart: degradation of kallidin by aminopeptidase M-like activity and bradykinin by neutral endopeptidase.

  1999cited by this paper
• Plasma levels on nociceptin in female fibromyalgia syndrome patients

  1998cited by this paper
• B1 kinin receptor activity in pigs is associated with pre-existing infection.

  1998cited by this paper
• Intraaccumbens injections of substance P, morphine and amphetamine: effects on conditioned place preference and behavioral activity.

  1998cited by this paper
• Alteration in the brain content of substance P (1-7) during withdrawal in morphine-dependent rats.

  1998cited by this paper
• Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.

  1998cited by this paper
• The Angiotensin II Type 2 (AT2) Receptor Promotes Axonal Regeneration in the Optic Nerve of Adult Rats

  1998cited by this paper
• Action of AT1 subtype angiotensin II receptors of the medial preoptic area on gonadotropins and prolactin release.

  1998cited by this paper
• Distinct mechanism for antidepressant activity by blockade of central substance P receptors.

  1998cited by this paper
• Effects of SR140333, a selective non‐peptide NK1 receptor antagonist, on trigemino‐thalamic nociceptive pathways in the rat

  1998cited by this paper
• The B1 receptors for kinins.

  1998cited by this paper
• Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors

  1998cited by this paper
• Important role for angiotensin III and IV in the brain renin-angiotensin system.

  1997cited by this paper
• Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor.

  1997cited by this paper
• Expression of D1 receptor, D2 receptor, substance P and enkephalin messenger RNAs in the neurons projecting from the nucleus accumbens.

  1997cited by this paper
• Synthesis and effects of active fragments of angiotensin II.

  1997cited by this paper
• A potent and selective endogenous agonist for the mu-opiate receptor.

  1997cited by this paper
• Pharmacological characterization of orphanin FQ/nociceptin and its fragments.

  1997cited by this paper
• Evidence for a physiological role of central calcitonin gene-related peptide (CGRP) receptors in the control of food intake in rats.

  1997cited by this paper
• Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors.

  1997cited by this paper
• Spinally administered dynorphin A produces long‐lasting allodynia: involvement of NMDA but not opioid receptors

  1997cited by this paper
• Inhibition of tongue reflex in rats by tooth pulp stimulation during cerebral ventricle perfusion with (6-11) substance P analogs.

  1997cited by this paper
• Spinal cord injury and anti-NGF treatment results in changes in CGRP density and distribution in the dorsal horn in the rat.

  1997cited by this paper
• Pharmacology and mechanisms of opioid analgesic activity

  1997cited by this paper
• Purification and characterization of substance P endopeptidase activities in the rat spinal cord.

  1997cited by this paper
• Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor.

  1997cited by this paper
• Nociceptin/Orphanin FQ Microinjected into Hippocampus Impairs Spatial Learning in Rats

  1997cited by this paper
• Endocytosis and recycling of G protein-coupled receptors.

  1997cited by this paper
• Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials.

  1996cited by this paper
• Diversity and selectivity of receptor-G protein interaction.

  1996cited by this paper
• Drug addiction: the yin and yang of hedonic homeostasis.

  1996cited by this paper
• Angiotensin II Induction of Neurite Outgrowth by AT2 Receptors in NG108-15 Cells

  1996cited by this paper
• Regulation of Motoneuronal Calcitonin Gene–related Peptide (CGRP) During Axonal Growth and Neuromuscular Synaptic Plasticity Induced by Botulinum Toxin in Rats

  1996cited by this paper
• The substance P amino-terminal metabolite substance P(1-7), administered peripherally, prevents the development of acute morphine tolerance and attenuates the expression of withdrawal in mice.

  1996cited by this paper
• Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ

  1996cited by this paper
• The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cells.

  1996cited by this paper
• Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor

  1995cited by this paper
• Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor

  1995cited by this paper
• Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors

  1995cited by this paper
• Degradation of lysylbradykinin by endopeptidase 24.11 and endopeptidase 24.15.

  1995cited by this paper
• Characterization of a functional angiotensin IV receptor on coronary microvascular endothelial cells.

  1995cited by this paper
• Calcitonin gene related peptide gene expression in collagen-induced arthritis.

  1995cited by this paper
• The role of neuropeptides in learning: focus on the neurokinin substance P.

  1995cited by this paper

• Dabsylated Bradykinin Is Cleaved by Snake Venom Proteases from Echis ocellatus

  2024cites this paper
• Neuropeptidomics of the American Lobster Homarus americanus.

  2024cites this paper
• Nocistatin and products of its proteolysis as dual modulators of type 3 acid-sensing ion channels (ASIC3) with an algesic and analgesic effect

  2023cites this paper
• Aminoprocalcitonin protects against hippocampal neuronal death via preserving oxidative phosphorylation in refractory status epilepticus

  2023cites this paper
• Trigeminal nerve stimulation: a current state-of-the-art review

  2023cites this paper
• Nocistatin and Products of Its Proteolysis Are Dual Modulators of Type 3 Acid-Sensing Ion Channels (ASIC3) with Algesic and Analgesic Properties

  2023cites this paper
• Simultaneous mass spectrometry imaging of multiple neuropeptides in the brain and alterations induced by experimental parkinsonism and L-DOPA therapy.

  2020cites this paper
• The Neuropeptide Kyotorphin as a Possible Biomarker and Neuroprotective Agent in Alzheimer’s Disease

  2020cites this paper
• Inhibitors of neuropeptide peptidases engaged in pain and drug dependence.

  2020cites this paper
• The effects of CGRP in vascular tissue - classical vasodilation and multiple shadowed effects.

  2020cites this paper
• Links to early-life stress and alcohol in male and female rats

  2020cites this paper
• Side-Chain Modification of Peptides Using a Phosphoranylidene Amino Acid.

  2020cites this paper
• Neuropeptides in Alzheimer's Disease: An Update.

  2019cites this paper
• The serum protease network-one key to understand complex regional pain syndrome pathophysiology.

  2019cites this paper
• Mycoplasma hyopneumoniae surface-associated proteases cleave bradykinin, substance P, neurokinin A and neuropeptide Y

  2019cites this paper
• Targeting Neuropathic Pain: Pathobiology, Current Treatment and Peptidomimetics as a New Therapeutic Opportunity.

  2019cites this paper
• An imidazole based H-Phe-Phe-NH2 peptidomimetic with anti-allodynic effect in spared nerve injury mice.

  2018cites this paper
• UPPSALA 2018 Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 249 Development of Substance P 1 – 7 Related Peptides and Peptidomimetics Targeting Neuropathic Pain ANNA SKOGH

  2018cites this paper
• Vascular and molecular pharmacology of the metabolically stable CGRP analogue, SAX

  2018cites this paper
• Profound loss of neprilysin accompanied by decreased levels of neuropeptides and increased CRP in ulcerative colitis

  2017cites this paper
• Importance of N‐ and C‐terminal residues of substance P 1–7 for alleviating allodynia in mice after peripheral administration

  2017cites this paper
• Angiotensin Peptides as AT2 Receptor Agonists.

  2017cites this paper
• Binding to and Inhibition of Insulin-Regulated Aminopeptidase by Macrocyclic Disulfides Enhances Spine Density

  2016cites this paper
• Minimizing Postsampling Degradation of Peptides by a Thermal Benchtop Tissue Stabilization Method

  2016cites this paper
• β-endorphin regulates alcohol consumption induced by exercise restriction in female mice.

  2016cites this paper
• Characterization of Substance P processing in mouse spinal cord S9 fractions using high-resolution Quadrupole-Orbitrap mass spectrometry.

  2016cites this paper
• Die geschlechtsspezifische Bedeutung von Isoformen der NO-Synthase für die Ang-(1-7) modifizierte Langzeitpotenzierung in der lateralen Amygdala

  2016cites this paper
• Evidence for involvement of NK₃ receptors in the anxiogenic-like effect of SP6-11(C-terminal), a metabolite of substance P, in rats evaluated in the elevated plus-maze.

  2016cites this paper
• Neuropeptides: Metabolism to Bioactive Fragments and the Pharmacology of Their Receptors

  2015cites this paper
• The Impact of the Neuropeptide Substance P (SP) Fragment SP1-7 on Chronic Neuropathic Pain

  2015influential citation
• Crypteins--an overlooked piece of peptide systems.

  2015cites this paper
• The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.

  2014cites this paper
• Exploration and pharmacokinetic profiling of phenylalanine based carbamates as novel substance p 1-7 analogues.

  2014cites this paper
• Analysis of the circadian system of the cockroach Rhyparobia (Leucophaea) maderae

  2013cites this paper
• Electroosmotic push-pull perfusion: description and application to qualitative analysis of the hydrolysis of exogenous galanin in organotypic hippocampal slice cultures.

  2013cites this paper
• Constrained H-Phe-Phe-NH2 analogues with high affinity to the substance P 1-7 binding site and with improved metabolic stability and cell permeability.

  2013cites this paper
• Use of Peptides as Drug Leads : A Case Story on the Development of Dipeptides Corresponding to the Heptapeptide Substance P(1-7), with Intriguing Effects on Neuropathic Pain

  2012cites this paper
• Cognition-enhancing peptides and peptidomimetics

  2012cites this paper
• Discovery of Inhibitors of Insulin-Regulated Aminopeptidase as Cognitive Enhancers

  2012cites this paper
• Dynorphin convertases and their functions in CNS.

  2012cites this paper
• Chapter 20 – Peptides

  2012cites this paper
• Neuropeptides as mediators of the early-life impact on the brain; implications for alcohol use disorders

  2012influential citation
• Impact of anabolic androgenic steroids on neuropeptide systems.

  2011cites this paper
• The dipeptide Phe-Phe amide attenuates signs of hyperalgesia, allodynia and nociception in diabetic mice using a mechanism involving the sigma receptor system

  2011cites this paper
• Neuromodulatory function of neuropeptides in the normal CNS.

  2011cites this paper
• The effect of substance P1-7 amide on nociceptive threshold in diabetic mice.

  2011cites this paper
• Substance P N-terminal fragment SP(1-7) attenuates chronic morphine tolerance and affects dynorphin B and nociceptin in rats.

  2011cites this paper
• Discovery of Small Peptides and Peptidomimetics Targeting the Substance P 1-7 Binding Site : Focus on Design, Synthesis, Structure-Activity Relationships and Drug-Like Properties

  2011cites this paper
• Chemokine Proteolytic Processing in HIV Infection: Neurotoxic and Neuroimmune Consequences

  2010cites this paper
• Chemokine Receptors and NeuroAIDS

  2010cites this paper
• Opioid peptides derived from food proteins suppress aggregation and promote reactivation of partly unfolded stressed proteins.

  2010cites this paper
• Physiological and pathophysiological functions of different angiotensins in the brain

  2010cites this paper
• Discovery of dipeptides with high affinity to the specific binding site for substance P1-7.

  2010cites this paper
• Substance P(1-7) induces antihyperalgesia in diabetic mice through a mechanism involving the naloxone-sensitive sigma receptors.

  2010cites this paper
• 84 – Genetic Transmission of Behavior and Its Neuroendocrine Correlates

  2009cites this paper
• Bioactive peptides, networks and systems biology

  2009cites this paper
• A Biological Role for the Gonadotrophin‐Releasing Hormone (GnRH) Metabolite, GnRH‐(1‐5)

  2009cites this paper
• Spectral clustering in peptidomics studies helps to unravel modification profile of biologically active peptides and enhances peptide identification rate

  2009cites this paper
• Targeting the insulin-regulated aminopeptidase/AT4 receptor for cognitive disorders.

  2009cites this paper
• Vagotomy enhances experimental metastases of 4THMpc breast cancer cells and alters substance P level.

  2008cites this paper
• Endomorphins interact with the substance P (SP) aminoterminal SP(1-7) binding in the ventral tegmental area of the rat brain.

  2008cites this paper
• Ligands to the (IRAP)/AT4 receptor encompassing a 4-hydroxydiphenylmethane scaffold replacing Tyr2.

  2008cites this paper
• Small peptides mimicking substance P (1-7) and encompassing a C-terminal amide functionality.

  2008cites this paper
• 2 Neuropeptides in the Immune System: Mediators of Stress and Inflammation

  2008cites this paper
• Small potent ligands to the insulin‐regulated aminopeptidase (IRAP)/AT4 receptor

  2007cites this paper
• Peptide conversion--a potential pathway modulating G-protein signaling.

  2007cites this paper
• LHRH-(1-5): a bioactive peptide regulating reproduction.

  2007cites this paper
• Enzymatic conversion of dynorphin A in the rat brain is affected by administration of nandrolone decanoate.

  2007cites this paper
• Neuropeptides in hyperthermia.

  2007cites this paper
• Plasticity and impact of the central renin–angiotensin system during development of ethanol dependence

  2007cites this paper
• 16 Low Molecular Weight Peptides

  2007cites this paper
• Terminating the stress: peripheral peptidolysis of proopiomelanocortin-derived regulatory hormones by the dermal microvascular endothelial cell extracellular peptidases neprilysin and angiotensin-converting enzyme.

  2007cites this paper
• Angiotensin converting enzyme has an inhibitory role in CGRP metabolism in human skin.

  2006cites this paper
• Capsaicin-induced inactivation of sensory neurons promotes a more aggressive gene expression phenotype in breast cancer cells

  2006cites this paper
• Anti-inflammatory effects of kinins via microglia in the central nervous system

  2006cites this paper
• Cyclic insulin‐regulated aminopeptidase (IRAP)/AT4 receptor ligands

  2006cites this paper
• Endomorphin-1 and endomorphin-2 differentially interact with specific binding sites for substance P (SP) aminoterminal SP1-7 in the rat spinal cord.

  2006cites this paper
• Administration of the anabolic androgenic steroid nandrolone decanoate affects substance P endopeptidase-like activity in the rat brain.

  2006cites this paper
• Proteolytic processing of SDF-1α reveals a change in receptor specificity mediating HIV-associated neurodegeneration

  2006cites this paper
• Modulation of peripheral inflammation by the substance P N-terminal metabolite substance P1-7.

  2006cites this paper
• Anabolic Steroid Abuse

  2006cites this paper
• The CNS renin-angiotensin system

  2006cites this paper
• Variations in opioid peptide levels during the estrous cycle in Sprague-Dawley rats.

  2006cites this paper
• Zen-Brain Reflections

  2006cites this paper
• Overview of the primary structure, tissue-distribution, and functions of tachykinins and their receptors.

  2006cites this paper
• Pathobiology of dynorphins in trauma and disease.

  2005cites this paper
• Deficit in beta-endorphin peptide and tendency to alcohol abuse.

  2005cites this paper
• Opioid and non-opioid activities of the dynorphins

  2005cites this paper
• New challenges in the study of the mammalian tachykinins.

  2005cites this paper
• The renin-angiotensin system in the mammalian central nervous system.

  2005cites this paper
• The impact of chronic nandrolone decanoate administration on the NK1 receptor density in rat brain as determined by autoradiography.

  2005cites this paper
• The substance P (SP) heptapeptide fragment SP1-7 alters the density of dopamine receptors in rat brain mesocorticolimbic structures during morphine withdrawal.

  2004cites this paper
• Opioid peptides in cerebrospinal fluid-methods for analysis and their significance in the clinical perspective.

  2004cites this paper
• Development of methods for protein and peptide analysis applied in neuroscience utilizing mass spectrometry.

  2004cites this paper
• Exogenous, but not endogenous nociceptin modulates mesolimbic dopamine release in mice

  2004cites this paper
• Opioid drugs as reinforcing stimuli in rhesus monkeys

  2004cites this paper
• PHARMACOLOGIC CHARACTERIZATION OF BRONCHOSPASM INDUCED BY SUBSTANCE P (SP) AND SP FRAGMENTS IN GUINEA-PIG

  2003cites this paper
• Nociceptin/Orphanin FQ and Its Receptor—Potential Targets for Pain Therapy?

  2003cites this paper
• Acta Universitatis Upsaliensis Uppsala 2008

  year unknowncites this paper